AMINOACYL PRODRUG DERIVATIVES AND MEDICAMENTS FOR THE TREATMENT OF THROMBOEMBOLITIC DISORDERS

The present application relates to prodrug derivatives of 5-chloro-N-({5S)-2-oxo-3-[4-(3-oxo-morpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of me...

Full description

Saved in:
Bibliographic Details
Main Authors KRENZ, URSULA, SCHLEMMER, KARL-HEINZ, PERZBORN, ELISABETH, LERCHEN, HANS-GEORG, KELDENICH, JOERG
Format Patent
LanguageEnglish
French
Published 12.08.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present application relates to prodrug derivatives of 5-chloro-N-({5S)-2-oxo-3-[4-(3-oxo-morpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.
AbstractList The present application relates to prodrug derivatives of 5-chloro-N-({5S)-2-oxo-3-[4-(3-oxo-morpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.
Author LERCHEN, HANS-GEORG
KELDENICH, JOERG
KRENZ, URSULA
PERZBORN, ELISABETH
SCHLEMMER, KARL-HEINZ
Author_xml – fullname: KRENZ, URSULA
– fullname: SCHLEMMER, KARL-HEINZ
– fullname: PERZBORN, ELISABETH
– fullname: LERCHEN, HANS-GEORG
– fullname: KELDENICH, JOERG
BookMark eNqFjLsKwkAQRbfQwtc3OD9gk0hSj7sTs5DNyuwYsJAQZK0kCcT_xwj2FocLh8tZq0U_9HGl7uhs7VHfKriwN3w9gyG2DYptKADWBhwZq9FRLQEKzyAlgTChfBX4Yhbs3cnTTGXFajA2eJ4zYauWz-41xd1vN2pfkOjyEMehjdPYPWIf363GJDsmaZ7p9P_jA4-1M9o
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DERIVES PROMEDICAMENTEUX AMINOACYLES ET MEDICAMENTS DESTINES AU TRAITEMENT DE MALADIES THROMBOEMBOLIQUES
ExternalDocumentID CA2642376C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2642376C3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:55:53 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2642376C3
Notes Application Number: CA20072642376
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140812&DB=EPODOC&CC=CA&NR=2642376C
ParticipantIDs epo_espacenet_CA2642376C
PublicationCentury 2000
PublicationDate 20140812
PublicationDateYYYYMMDD 2014-08-12
PublicationDate_xml – month: 08
  year: 2014
  text: 20140812
  day: 12
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies BAYER HEALTHCARE AG
RelatedCompanies_xml – name: BAYER HEALTHCARE AG
Score 2.9499998
Snippet The present application relates to prodrug derivatives of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title AMINOACYL PRODRUG DERIVATIVES AND MEDICAMENTS FOR THE TREATMENT OF THROMBOEMBOLITIC DISORDERS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140812&DB=EPODOC&locale=&CC=CA&NR=2642376C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvVNUYPffTB7WwxbYe5hMaPtZIZtZBsEHwxZYURfBpEZ_32vE9QXHpo016Rpr73e_a69K8DdrEOlZUwz3aLtTKdzmul2PuvgXs5wTeamMbVU7HAQdnpD-jxuj2vwtomFqfKEflXJEVGipijvZXVeL_-cWLx6W7m6l-9IWjx6qcO1NTpGtIAKS-NdRwwiHjGNMYe5Whg7qPfV-w-2A7toRFtKFsSoq2JSlv8VincEewPsqyiPoZYXDThgm3_XGrAfrK-7sbqWvNUJvLqBH0Yue-mTQRzxePhEOGKwkZv6I5EQN-TkJ1OjSs6fEMR2JO0JksbCTRWJRB4S4ijoRgJL3099RrifIAYUcXIKt55IWU_HcU5-WTJh7mZC5hnUi0WRN4GgadF6sCmVbWnR3LZla26YNEeLz86kNMxzaG7r5WJ70yUcKsYqP2rLuIJ6-fGZX6MiLuVNxcNv-vCFng
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEG8QjfimqMFP-mD2thhGYe5hMaPt3HQfZCsEHwxZYURfBpEZ_32vE9QXH5o016Rpr73e_a69K0I38z6RpjHLdJP0Mp0sSKZb-bwPezmDNVl0jZmpYofDqO-NyOOkN6mh120sTJUn9LNKjggSNQN5L6vzevXrxGLV28r1rXwD0vLeFTbTNugY0AIoLI0NbD6MWUw1Sm3qaFFig95X7z_oDtoFA9tUssDHAxWTsvqrUNxDtDeEvoryCNXyookadPvvWhPth5vrbqhuJG99jF6c0I9ihz4HeJjELBk9YAYYbOwIf8xT7EQMf2dqVMn5UwzYDguPY5FwRygSjl0gJHE4iDmUwBc-xcxPAQPyJD1BbZcL6ukwzukPS6bU2U6oe4rqxbLIWwiDadG5swiRPWmS3LJkZ2F0SQ4Wn5VJaXTPUOu_Xs7_b2qjhifCYBr40dMFOlBMVj7VjnGJ6uX7R34FSrmU1xU_vwBrm4iR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=AMINOACYL+PRODRUG+DERIVATIVES+AND+MEDICAMENTS+FOR+THE+TREATMENT+OF+THROMBOEMBOLITIC+DISORDERS&rft.inventor=KRENZ%2C+URSULA&rft.inventor=SCHLEMMER%2C+KARL-HEINZ&rft.inventor=PERZBORN%2C+ELISABETH&rft.inventor=LERCHEN%2C+HANS-GEORG&rft.inventor=KELDENICH%2C+JOERG&rft.date=2014-08-12&rft.externalDBID=C&rft.externalDocID=CA2642376C